BBS-Bioactive Bone Substitutes Plc is a health technology company. The firm engages in the development, research, production and manufacture of bioactive bone substitute implants. Its orthobiological product, ARTEBONE, is made of long bones of reindeers that have a superior capability for bone regeneration compared to existing allograft products. The company was founded by Pekka Kalevi Aleksanteri Jalovaara in 2003 and is headquartered in Oulu, Finland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company